Antihypertensive effects of ACE inhibitor perindopril: ASCOT-BLPA Study lessons
Antihypertensive effects of an ACE inhibitor perindopril were analyzed. In ASCOT-BPLA Study, blood pressure (BP) level for amlodipine ± perindopril treatment was lower than for atenolol ± bendroflumethiazide treatment (mean difference 2.7/1.9 mm Hg). Maximal BP difference was 5.9/2.4 mm Hg, by Month...
Main Author: | |
---|---|
Format: | Article |
Language: | Russian |
Published: |
«SILICEA-POLIGRAF» LLC
2006-06-01
|
Series: | Кардиоваскулярная терапия и профилактика |
Subjects: | |
Online Access: | https://cardiovascular.elpub.ru/jour/article/view/1204 |
_version_ | 1797882795806162944 |
---|---|
author | Yu. M. Lopatin |
author_facet | Yu. M. Lopatin |
author_sort | Yu. M. Lopatin |
collection | DOAJ |
description | Antihypertensive effects of an ACE inhibitor perindopril were analyzed. In ASCOT-BPLA Study, blood pressure (BP) level for amlodipine ± perindopril treatment was lower than for atenolol ± bendroflumethiazide treatment (mean difference 2.7/1.9 mm Hg). Maximal BP difference was 5.9/2.4 mm Hg, by Month 3 of the therapy. Results of large-scale studies, confirming perindopril high efficacy and safety in arterial hypertension patients, were presented. |
first_indexed | 2024-04-10T03:40:22Z |
format | Article |
id | doaj.art-36549eaf4c91424782caffecf5d3ca18 |
institution | Directory Open Access Journal |
issn | 1728-8800 2619-0125 |
language | Russian |
last_indexed | 2024-04-10T03:40:22Z |
publishDate | 2006-06-01 |
publisher | «SILICEA-POLIGRAF» LLC |
record_format | Article |
series | Кардиоваскулярная терапия и профилактика |
spelling | doaj.art-36549eaf4c91424782caffecf5d3ca182023-03-13T07:23:12Zrus«SILICEA-POLIGRAF» LLCКардиоваскулярная терапия и профилактика1728-88002619-01252006-06-01538387916Antihypertensive effects of ACE inhibitor perindopril: ASCOT-BLPA Study lessonsYu. M. Lopatin0Волгоградский государственный медицинский университет; Волгоградский областной кардиологический центр. ВолгоградAntihypertensive effects of an ACE inhibitor perindopril were analyzed. In ASCOT-BPLA Study, blood pressure (BP) level for amlodipine ± perindopril treatment was lower than for atenolol ± bendroflumethiazide treatment (mean difference 2.7/1.9 mm Hg). Maximal BP difference was 5.9/2.4 mm Hg, by Month 3 of the therapy. Results of large-scale studies, confirming perindopril high efficacy and safety in arterial hypertension patients, were presented.https://cardiovascular.elpub.ru/jour/article/view/1204артериальная гипертонияингибиторы апфпериндоприл |
spellingShingle | Yu. M. Lopatin Antihypertensive effects of ACE inhibitor perindopril: ASCOT-BLPA Study lessons Кардиоваскулярная терапия и профилактика артериальная гипертония ингибиторы апф периндоприл |
title | Antihypertensive effects of ACE inhibitor perindopril: ASCOT-BLPA Study lessons |
title_full | Antihypertensive effects of ACE inhibitor perindopril: ASCOT-BLPA Study lessons |
title_fullStr | Antihypertensive effects of ACE inhibitor perindopril: ASCOT-BLPA Study lessons |
title_full_unstemmed | Antihypertensive effects of ACE inhibitor perindopril: ASCOT-BLPA Study lessons |
title_short | Antihypertensive effects of ACE inhibitor perindopril: ASCOT-BLPA Study lessons |
title_sort | antihypertensive effects of ace inhibitor perindopril ascot blpa study lessons |
topic | артериальная гипертония ингибиторы апф периндоприл |
url | https://cardiovascular.elpub.ru/jour/article/view/1204 |
work_keys_str_mv | AT yumlopatin antihypertensiveeffectsofaceinhibitorperindoprilascotblpastudylessons |